In utero and at birth diagnosis of congenital toxoplasmosis: Use of likelihood ratios for clinical management

Pediatric Infectious Disease Journal

Volumn 29, Issue 5, 2010, Pages 421-425

  Rabilloud, Muriel ^a,b,c,d,e   Wallon, Martine ^b,c,f   Peyron, François ^b,c  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CNRS   (France)

^e LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^f CROIX ROUSSE HOSPITAL   (France)

Author keywords

Antenatal and neonatal diagnosis; Congenital toxoplasmosis; Likelihood ratios; Posttest probability; Sensitivity and specificity

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN M;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; FRANCE; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NEWBORN; NEWBORN CARE; NEWBORN PERIOD; PARENT COUNSELING; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRENATAL PERIOD; PRIORITY JOURNAL; PROBABILITY; RELIABILITY; SENSITIVITY AND SPECIFICITY; TOXOPLASMA GONDII;

ANTIBODIES, PROTOZOAN; DNA, PROTOZOAN; FEMALE; FRANCE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INFANT, NEWBORN; MALE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 77951872344     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181c80493     Document Type: Article

References (30)

1. Wallon M, Kodjikian L, Binquet C, et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics. 2004;113:1567-1572.
2. Aspöck H. Prevention of congenital toxoplasmosis in Austria. Arch Pediatr. 2003;10(suppl 1):16-17.
3. Ambroise-Thomas P, Schweitzer M, Pinon JM, et al. Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up. Bull Acad Natl Med. 2001; 185:665-683.
4. Buffolano W. Failure to implement a preventive strategy against congenital toxoplasmosis in Italy. Arch Pediatr. 2003;(suppl 1):21-22.
5. Logar J, Petrovec M, Novak-Antolic Z, et al. Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women. Scand J Infect Dis. 2002;34:201-204.
6. Gras L, Wallon M, Pollak A, et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Pediatr. 2005;94:1721-1731.
7. Signorell LM, Seitz D, Merkel S, et al. Cord blood screening for congenital toxoplasmosis in Northwestern Switzerland, 1982-1999. Pediatr Infect Dis J. 2006;25:123-128.
8. Vendrell JP, Pratlong F, Decoster A, et al. Secretion of Toxoplasma gondii specific antibody in vitro by peripheral blood mononuclear cells as a new marker of acute toxoplasmosis. Clin Exp Immunol. 1992;89:126-130.
9. Wallon M, Dunn D, Slimani D, et al. Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA? Eur J Pediatr. 1999;158:645-649.
10. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004; 329:168-169.
11. Lebech M, Joynson DH, Seitz HM, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis. 1996;15:799-804.
12. Romand S, Wallon M, Franck J, et al. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol. 2001;97:296-300.
13. Janssens AC, Deng Y, Borsboom GJ, et al. A new logistic regression approach for the evaluation of diagnostic test results. Med Decis Making. 2005;25:168-177.
14. Foulon W, Pinon JM, Stray-Pedersin B, et al. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol. 1999;181:843-847. (Pubitemid 29503601)
15. Robert-Gangneux F, Gavinet MF, Ancelle T, et al. Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J Clin Microbiol. 1999;37:2893-2898.
16. Roman S, Chosson M, Franck J, et al. Usefulness of quantitative polymer-ase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am J Obstet Gynecol. 2004;190:797-802.
17. Thalib L, Gras L, Romand S, et al. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG. 2005;112: 567-574.
18. Gilbert RE, Thalib L, Tan HK, et al. Screening for congenital toxoplasmo-sis; accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen. 2007;14:8-13.
19. Odibo AO, Gray DL, Dicke JM, et al. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience. Obstet Gynecol. 2008;111:589-595.
20. Gay-Andrieu F, Marty P, Pialat J, et al. Fetal toxoplasmosis and negative amniocentesis: necessity of an ultrasound follow-up. Prenat Diagn. 2003; 23:558-560.
21. Gilbert RE, Gras L, Wallon M, et al. Effect of prenatal treatment in mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol. 2001;30:1303-1308.
22. Wallon M, Gaucherand P, Al Kurdi M, et al. Toxoplasma infections in early pregnancy: consequences and management. J Gynecol Obstet Biol Reprod. 2002;31:478-484.
23. Berrebi A, Bardou M, Bessieres MH, et al. Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: a study of 36 cases. Eur J Obstet Gynecol Reprod Biol. 2007;135:53-57.
24. Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008;47:554-566.
25. Grover CM, Thulliez P, Remington JS, et al. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol. 1990;28:2297-2301.
26. Filisetti D, Gorcii M, Pernot-Marino E, et al. Diagnosis of congenital toxoplasmosis: comparison of targets for detection of Toxoplasma gondii by PCR. J Clin Microbiol. 2003;41:4826-4828.
27. Derouin F. Drugs effective against Toxoplasma gondii. Present status and future perspective. In: Amboise-Thomas P, Petersen E, eds. Congenital Toxoplasmosis. Scientific Background, Clinical Management and Control. Paris: Springer Verlag; 2000:95-110.
28. Pinon JM, Dumon H, Chemla C, et al. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol. 2001;39:2267-2271.
29. Correa D, Cañedo-Solares I, Ortiz-Alegria LB, et al. Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host. Parasite Immunol. 2007;29:651-660.
30. Remington JS, Thulliez P, Montoya JG. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol. 2004;42:941-945.